Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Boston Scientific
BSX
|
+$241M |
| 2 |
eBay
EBAY
|
+$225M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$211M |
| 4 |
Ameren
AEE
|
+$200M |
| 5 |
Kohl's
KSS
|
+$188M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$532M |
| 2 |
Micron Technology
MU
|
+$463M |
| 3 |
Marathon Petroleum
MPC
|
+$239M |
| 4 |
Visa
V
|
+$222M |
| 5 |
Halliburton
HAL
|
+$206M |
Sector Composition
| 1 | Financials | 14.36% |
| 2 | Healthcare | 12.69% |
| 3 | Technology | 12.35% |
| 4 | Industrials | 11.66% |
| 5 | Consumer Discretionary | 11.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Celsius Holdings
CELH
$14.9B
| $932K | ﹤0.01% |
642,786
+382,164
| +147% | +$554K |
|
2502
Gold Resource Corp
GORO
$133M
| $932K | ﹤0.01% |
206,743
+55,484
| +37% | +$250K |
|
2503
Olympic Steel
ZEUS
$368M
| $930K | ﹤0.01% |
+45,343
| New | +$930K |
|
2504
Donaldson
DCI
$9.42B
| $928K | ﹤0.01% |
20,604
-589,749
| -97% | -$26.6M |
|
2505
iShares Mortgage Real Estate ETF
REM
$610M
| $928K | ﹤0.01% |
+21,834
| New | +$928K |
|
|
ISEE
2506
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $928K | ﹤0.01% |
338,512
-669,378
| -66% | -$1.84M |
|
2507
Cohen & Steers REIT and Preferred and Income Fund
RNP
$1.07B
| $927K | ﹤0.01% |
49,575
+32,708
| +194% | +$612K |
|
2508
Gildan
GIL
$8.03B
| $926K | ﹤0.01% |
32,036
+14,506
| +83% | +$419K |
|
|
MDSO
2509
DELISTED
Medidata Solutions, Inc.
MDSO
| $923K | ﹤0.01% |
14,697
-24,235
| -62% | -$1.52M |
|
|
SGYP
2510
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $923K | ﹤0.01% |
504,383
+485,558
| +2,579% | +$889K |
|
2511
Southwest Airlines
LUV
$16.6B
| $920K | ﹤0.01% |
16,064
-1,326,354
| -99% | -$76M |
|
|
STML
2512
DELISTED
Stemline Therapeutics, Inc.
STML
| $919K | ﹤0.01% |
60,056
-229,949
| -79% | -$3.52M |
|
2513
Hovnanian Enterprises
HOV
$895M
| $918K | ﹤0.01% |
20,056
+16,374
| +445% | +$749K |
|
2514
Ituran Location and Control
ITRN
$696M
| $918K | ﹤0.01% |
29,519
-8,832
| -23% | -$275K |
|
|
FSNN
2515
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
| $917K | ﹤0.01% |
189,220
+172,866
| +1,057% | +$838K |
|
2516
BlackRock Enhanced Global Dividend Trust
BOE
$650M
| $915K | ﹤0.01% |
79,127
+60,741
| +330% | +$702K |
|
|
PTLA
2517
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $913K | ﹤0.01% |
27,959
+17,658
| +171% | +$577K |
|
2518
Primis Financial Corp
FRST
$269M
| $912K | ﹤0.01% |
+57,573
| New | +$912K |
|
|
CURO
2519
DELISTED
CURO Group Holdings Corp.
CURO
| $912K | ﹤0.01% |
52,996
-63,089
| -54% | -$1.09M |
|
|
TBHC
2520
The Brand House Collective, Inc. Common Stock
TBHC
$53.2M
| $911K | ﹤0.01% |
94,030
-62,429
| -40% | -$605K |
|
2521
MakeMyTrip
MMYT
$9.31B
| $910K | ﹤0.01% |
+26,229
| New | +$910K |
|
2522
Dynavax Technologies
DVAX
$1.1B
| $906K | ﹤0.01% |
45,648
-55,389
| -55% | -$1.1M |
|
2523
Calix
CALX
$4.01B
| $904K | ﹤0.01% |
132,014
-56,973
| -30% | -$390K |
|
|
ZYNE
2524
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $903K | ﹤0.01% |
+103,941
| New | +$903K |
|
2525
Verastem
VSTM
$598M
| $901K | ﹤0.01% |
25,185
-4,616
| -15% | -$165K |
|